Clinical trials
Terminated Phase 2 Uterine Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2006 | 3 |
| 2008 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| Elevation Oncology | 1 |
| Mark H. Einstein | 1 |
| Pfizer | 1 |
| Sanofi | 1 |
| University of Alabama at Birmingham | 1 |
| University of Oklahoma | 1 |
| University of Wisconsin, Madison | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Neoplasms | 11 |
| Ovarian Neoplasms | 4 |
| Neoplasm Metastasis | 2 |
| Prostatic Neoplasms | 2 |
| Urinary Bladder Neoplasms | 2 |
| Uterine Cervical Neoplasms | 2 |
| Adenocarcinoma, Clear Cell | 1 |
| Anus Neoplasms | 1 |
| Bile Duct Neoplasms | 1 |
| Breast Neoplasms | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.